D.A. Davidson & CO. Buys 3,871 Shares of The Clorox Company (NYSE:CLX)

D.A. Davidson & CO. increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 23.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 20,107 shares of the company's stock after buying an additional 3,871 shares during the period. D.A. Davidson & CO.'s holdings in Clorox were worth $2,961,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Redwood Park Advisors LLC acquired a new stake in Clorox in the 4th quarter worth about $26,000. Millstone Evans Group LLC acquired a new stake in Clorox in the 4th quarter worth about $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox in the 4th quarter worth about $31,000. GKV Capital Management Co. Inc. acquired a new stake in Clorox in the 4th quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Clorox in the 4th quarter worth about $33,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CLX shares. Citigroup dropped their target price on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Barclays dropped their target price on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. JPMorgan Chase & Co. dropped their target price on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Wells Fargo & Company dropped their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Finally, Morgan Stanley dropped their target price on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, Clorox presently has an average rating of "Hold" and a consensus price target of $149.50.

Clorox Stock Up 0.1%

Clorox stock opened at $124.80 on Monday. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The firm's fifty day moving average is $129.65 and its 200 day moving average is $143.60. The company has a market capitalization of $15.38 billion, a PE ratio of 22.41, a PEG ratio of 3.04 and a beta of 0.51.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the firm earned $1.71 EPS. The firm's revenue was down 8.0% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The stock was bought at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director directly owned 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.